L-Threonine

Evidence Level
Preliminary
1 Clinical Trial
5 Documented Benefits
1/5 Evidence Score

L-Threonine is an essential amino acid required for collagen and elastin synthesis, immune function, fat metabolism, and central nervous system function. Found in meat, fish, dairy, eggs, lentils, soy. Standalone supplementation is rare — most use is via complete protein or EAA blends. There is very little human evidence for taking it on its own. The cited human work is a study of how much threonine the body needs plus one small 1991 trial in 18 people with a rare inherited nerve condition; the gut and immune research was done in pigs and pig cells. In people eating enough protein, isolated threonine supplementation has no demonstrated benefit.

Studied Dose The single cited human trial used 4.5 to 6.0 g/day in 18 patients with a rare inherited nerve condition, not healthy people; dietary needs are roughly 10 to 20 mg per kg of body weight per day.
Active Compound L-Threonine (free amino acid)

Benefits

Collagen and Elastin Synthesis

L-Threonine is one of the amino acid building blocks the body uses to make collagen and elastin, the proteins in skin, tendons and connective tissue. That is basic biochemistry, not a tested effect. No human study of threonine supplements and skin, hair, nails, joints or tendons is cited on this page, so there is no evidence that taking extra does more than eating enough protein.

Mucin / Gut Mucosal Layer

L-Threonine is a major component of mucin glycoproteins — the protective mucosal layer lining the GI tract. The cited research is entirely in pigs: a feeding study in growth-restricted weanling piglets found more intestinal mucin, and a laboratory study used pig intestinal cells in a dish. No human study has tested this.

Immune Function

Threonine is used to build antibodies, and a severe shortage impairs antibody production, which is rare on a protein-adequate diet. The immune findings cited here come from piglets and from pig intestinal cells in a dish, not from people. No cited study shows that extra threonine improves immunity in a well-fed person.

Studied in a Rare Inherited Nerve Condition (Not a Consumer Benefit)

This is medical research, not a benefit for healthy people. In 1991 a double-blind crossover trial gave 4.5 to 6.0 grams a day of L-threonine to 18 people with familial spastic paraparesis, a rare inherited condition that causes muscle stiffness. Signals were modest, the trial was tiny and more than 30 years old, and it never became standard care, which is still physical therapy and prescription medicines. Nothing here means a supplement treats any disease.

Glycine Pathway: Theoretical Only

Because the body can convert threonine into glycine, researchers once explored it in serious neurological illness. No trial supporting that is cited on this page, and no dietary supplement treats, slows or prevents a neurodegenerative disease. Anyone facing a neurological diagnosis should be guided by a neurologist.

Mechanism of action

1

Protein Synthesis

Essential amino acid required for ribosomal protein synthesis. Hydroxyl side chain provides O-glycosylation sites in mucins and other glycoproteins.

2

Glycine Pathway

L-Threonine can be metabolized to glycine via threonine dehydrogenase + serine hydroxymethyltransferase. This is a proposed, unproven explanation for why threonine was once tested in neurological research. It has not been confirmed in people, and no cited study measured glycine receptor activity in humans.

3

Mucin Synthesis

Threonine is heavily represented in mucin protein backbones (alongside serine and proline) — the heavily-glycosylated proteins forming the protective mucosal layer in the GI tract and respiratory tract.

4

Lipotropic Effects

Older animal nutrition work describes threonine as a lipotropic factor alongside choline, methionine and inositol, meaning diets short of it led to fat building up in the liver. No study cited on this page tested this in humans, and none tested a threonine supplement for liver fat.

Clinical trials

1
1991 Trial in 18 People With Familial Spastic Paraparesis

Double-blind, placebo-controlled crossover trial of L-threonine at 4.5 to 6.0 grams a day (Growdon 1991, Clinical Neuropharmacology). The dose was lower than the 7.5 grams a day quoted elsewhere for this use.

18 people with familial spastic paraparesis, a rare inherited neurological condition. No healthy volunteers were studied.

Modest changes in muscle stiffness in some participants, in a group of only 18 people and more than 30 years ago. The result was not consistently replicated and never became standard care, which remains physical therapy and prescription muscle relaxants such as baclofen or tizanidine. This is the only human trial of L-threonine supplementation cited anywhere on this page.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated.
GI distress (nausea, soft stools) at high doses.
Headache reported rarely.

Important Drug interactions

MAOIs — minimal direct interaction; theoretical via amino acid metabolism.
Anticonvulsants — theoretical interaction via glycine pathway; not clinically established.

Frequently asked questions about L-Threonine

What is L-threonine used for?

L-threonine is an essential amino acid, meaning your body cannot make it and has to get it from food such as meat, fish, eggs, dairy, lentils and soy. It is used as a building block for collagen and elastin, for antibodies, and for the mucus layer lining the gut. Most of the gut and immune research was done in pigs, and no cited human study shows that taking it as a separate supplement adds anything for someone already eating enough protein.

What is L-threonine good for?

Your body uses it to build connective tissue, the gut mucus lining and antibodies. Beyond that the evidence is thin: the only cited human trial was in 18 people with a rare inherited nerve condition, and the gut and immune studies were in pigs. It is normally obtained from dietary protein rather than taken on its own.

How much L-threonine should I take?

It is typically consumed through dietary protein; supplemental amounts, when used, follow product labeling. A balanced protein intake supplies adequate threonine for most people.

Is L-threonine safe?

As an essential amino acid from normal protein intake it is generally safe and well tolerated. High-dose isolated supplementation is rarely needed. Those with medical conditions should check with a doctor.

What is L-Threonine?

L-Threonine is an essential amino acid required for collagen and elastin synthesis, immune function, fat metabolism, and central nervous system function. Found in meat, fish, dairy, eggs, lentils, soy. Standalone supplementation is rare — most use is via complete protein or EAA blends.

What is the recommended dosage of L-Threonine?

The clinically studied dose is The single cited human trial used 4.5 to 6.0 g/day in 18 patients with a rare inherited nerve condition, not healthy people; dietary needs are roughly 10 to 20 mg per kg of body weight per day. Always follow the product label and check with a healthcare provider for personal advice.

Is L-Threonine safe, and does it have side effects?

For most healthy adults, L-Threonine is well tolerated at studied doses. Reported effects can include: Generally well-tolerated. GI distress (nausea, soft stools) at high doses. It may also interact with some medications. L-Threonine is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does L-Threonine interact with any medications?

Possible interactions include: MAOIs — minimal direct interaction; theoretical via amino acid metabolism. Anticonvulsants — theoretical interaction via glycine pathway; not clinically established. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for L-Threonine?

NutraSmarts rates the evidence for L-Threonine as Preliminary (1 out of 5). It is backed by 1 clinical trial and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Szwiega S, Pencharz PB, Ball RO, Xu L, Kong D, Elango R, Courtney-Martin G Length of Adaptation Has No Effect on the Threonine Requirement Determined in Healthy Young Adult Males Using the Indicator Amino Acid Oxidation Method The Journal of Nutrition. 2023;153(7):2016-2026. doi:10.1016/j.tjnut.2023.03.033.PubMedUsed to support: Human study establishing L-threonine requirement (~10–12 mg/kg/day) in healthy adult males using indicator amino acid oxidation; this establishes how much threonine the body needs. It did not test taking a threonine supplement and shows no benefit from extra intake.
  2. Wang C, Yang Y, Gao N, Lan J, Dou X, Li J, Shan A L-Threonine upregulates the expression of β-defensins by activating the NF-κB signaling pathway and suppressing SIRT1 expression in porcine intestinal epithelial cells Food & Function. 2021;12(13):5821-5836. doi:10.1039/d1fo00269d.PubMedUsed to support: Mechanistic cell-biology study (porcine intestinal epithelial cells) showing L-threonine upregulates β-defensin expression and mucosal barrier function via NF-κB signaling. Done entirely in pig intestinal cells in a dish. It is a mechanism study only and shows nothing about mucus or immunity in people.
  3. Zhang H, Chen Y, Li Y, Zhang T, Ying Z, Su W, Zhang L, Wang T l-Threonine improves intestinal mucin synthesis and immune function of intrauterine growth-retarded weanling piglets Nutrition. 2019;59:182-187. doi:10.1016/j.nut.2018.07.114.PubMedUsed to support: Animal study (piglets) demonstrating that dietary L-threonine supplementation increases intestinal mucin synthesis, strengthens mucosal barrier, and enhances immune markers. Piglet feeding study. It measured intestinal mucin and immune markers only and did not measure collagen or elastin. Animal evidence, not a human trial.
  4. Growdon JH, Nader TM, Schoenfeld J, Wurtman RJ L-threonine in the treatment of spasticity Clinical Neuropharmacology. 1991;14(5):403-12. doi:10.1097/00002826-199110000-00003.PubMedUsed to support: Double-blind crossover clinical trial (n=18 patients with familial spastic paraparesis) of L-threonine at 4.5–6.0 g/day vs placebo; the participants were patients with a rare inherited disease, not healthy people, and this is the only human supplementation trial cited on this page. Note the dose was 4.5 to 6.0 g/day, lower than the 7.5 g/day often quoted.